Reuters logo
BRIEF-Marksans Pharma says USFDA gives four 483 observations to manufacturing facilties in Goa
April 10, 2017 / 7:15 AM / 6 months ago

BRIEF-Marksans Pharma says USFDA gives four 483 observations to manufacturing facilties in Goa

April 10 (Reuters) - Marksans Pharma Ltd

* Marksans Pharma Ltd says USFDA inspects manufacturing facilty at L-82, L-83 in Goa

* Marksans Pharma Ltd says 4 observations given under form 483

* Marksans Pharma Ltd says co started addressing observations

* Marksans Pharma Ltd says USFDA granted final approval for ANDA for dutasteride soft gealtine capsule Source text: (bit.ly/2oh2IVe) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below